Chemours (NYSE:CC – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by research analysts at Morgan Stanley in a research report issued to clients and investors on Tuesday, Benzinga reports. They currently have a $33.00 target price on the specialty chemicals company’s stock. Morgan Stanley’s price objective points to a potential downside of […]
Chemours (NYSE:CC – Get Free Report) released its quarterly earnings data on Friday. The specialty chemicals company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.01, MarketWatch Earnings reports. Chemours had a net margin of 7.45% and a return on equity of 53.44%. The business had revenue […]
Yousif Capital Management LLC reduced its position in The Chemours Company (NYSE:CC – Free Report) by 2.8% during the first quarter, Holdings Channel.com reports. The firm owned 78,815 shares of the specialty chemicals company’s stock after selling 2,260 shares during the quarter. Yousif Capital Management LLC’s holdings in Chemours were worth $2,360,000 as of its […]
Quantinno Capital Management LP lowered its holdings in shares of The Chemours Company (NYSE:CC – Free Report) by 57.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 27,387 shares of the specialty chemicals company’s stock after selling 37,121 shares during the period. Quantinno Capital […]
The Chemours Company (NYSE:CC – Get Free Report) declared a quarterly dividend on Wednesday, July 26th, NASDAQ reports. Stockholders of record on Tuesday, August 15th will be paid a dividend of 0.25 per share by the specialty chemicals company on Friday, September 15th. This represents a $1.00 dividend on an annualized basis and a dividend […]